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Abstract
Intravenous injections of cocaine HCl are habit-forming because, among their many actions, they elevate extracellular
dopamine levels in the terminal fields of the mesocorticolimbic dopamine system. This action, thought to be very important
for cocaine’s strong addiction liability, is believed to have very short latency and is assumed to reflect rapid brain entry and
pharmacokinetics of the drug. However, while intravenous cocaine HCl has almost immediate effects on behavior and
extracellular dopamine levels, recent evidence suggests that its central pharmacological effects are not evident until 10 or
more seconds after IV injection. Thus the immediate effects of a given intravenous cocaine injection on extracellular
dopamine concentration and behavior appear to occur before there is sufficient time for cocaine to act centrally as a
dopamine uptake inhibitor. To explore the contribution of peripheral effects of cocaine to the early activation of the
dopamine system, we used brain microdialysis to measure the effects of cocaine methiodide (MI)—a cocaine analogue that
does not cross the blood brain barrier—on glutamate (excitatory) input to the dopamine cells. IP injections of cocaine MI
were ineffective in cocaine-naı ¨ve animals but stimulated ventral tegmental glutamate release in rats previously trained to
lever-press for cocaine HCl. This peripherally triggered glutamate input was sufficient to reinstate cocaine-seeking in
previously trained animals that had undergone extinction of the habit. These findings offer an explanation for short-latency
behavioral responses and immediate dopamine elevations seen following cocaine injections in cocaine-experienced but not
cocaine-naı ¨ve animals.
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Introduction
Cocaine has multiple pharmacological actions in both the central
and peripheral nervous systems. It potentiates the actions of the
monoamine neurotransmitters by blocking reuptake through each
of the plasmalemmal monoamine transporters [1] and it also acts as
a local anesthetic, blocking voltage-gated sodium and calcium
channels and calcium-activated potassium channels [2,3,4,5]. The
hydrochloride (HCl) salt of cocaine dissociates in solution at
physiological pH, and free cocaine readily crosses the blood brain
barrier. Its addiction liability derives primarily from its ability to
increase dopamine concentration [6,7] and, thus, dopamine
receptor activation [8,9] in the terminal fields of the mesocortico-
limbic dopamine system [10,11,12]. Intravenous (IV) cocaine HCl
has almost immediate behavioral and cardiovascular effects, effects
that have been assumed to result from its rapid entry to the brain
[13,14]. It is thought that the rapid onset of the effects cocaine HCl
explains much of its addictive power [15,16,17]; it is known that the
delay of a single second between an instrumental response and the
delivery of reinforcement to the brain can dramatically dilute the
effectiveness of the reinforcer [18,19]. Against the single-second
standard, however, the central pharmacological effects of cocaine
HCl are not particularly fast. The latency for onset of central
pharmacological actions after intravenous injection of cocaine HCl
in cocaine-naı ¨ve animals appears to be greater than 10 seconds [20]
with peak effects tens of seconds later [21,22]. Meanwhile, cocaine
HCl-induced extracellular dopamine increases are evident in
cocaine-trained animals at much shorter latency [20,23]. This very
short-latency effect of cocaine HCl is not detected in freely moving
animals without prior cocaine experience [20] and it is lost after
extinction of the cocaine-rewarded response [24]. A very short
latency dopamine response to cocaine HCl can also be seen in
cocaine-naı ¨ve anesthetized animals [25], but this response is not
strong enough to be detected in freely moving animals [20].
Recent electrophysiological and microdialysis studies suggest the
possibility that, rather than an effect of blocked dopamine
reuptake, the significant immediate dopamine elevation reflects
conditioned dopamine release triggered by cocaine-predictive cues.
Electrophysiological studies show that reward-predictive environ-
mental stimuli come to activate the dopamine system [26]. This
activation involves 200 msec bursts of dopaminergic firing
triggered by sensory-evoked synaptic input to the dopaminergic
cells in the VTA. Microdialysis studies show that cocaine-
predictive cues can cause VTA glutamate release, and that this
release causes local dendritic release of dopamine [27], a correlate
of dopaminergic cell firing [28,29,30]. The ability of cocaine to
evoke glutamate release in the VTA is seen only in cocaine-
experienced, not cocaine-naı ¨ve, animals [27,31].
Among the sensory events that can trigger conditioned
responses to ingested substances are the immediate interoceptive
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used cocaine methiodide (cocaine MI), a quaternary cocaine
analogue that does not cross the blood-brain barrier, to determine
if the interoceptive stimulus effects of cocaine itself can become
conditioned to trigger VTA glutamate release, VTA dopamine
release, and cocaine-seeking behavior.
Results and Discussion
In our initial experiment we monitored ventral tegmental
glutamate and dopamine release during cocaine HCl-induced
(‘‘cocaine-primed’’) reinstatement of cocaine-seeking in an animal
model of addiction relapse [33]. Here, rats were first trained to
lever-press for intravenous cocaine HCl. After two weeks of daily
training, the rats underwent three weeks of daily ‘‘extinction’’ trials
in which they were allowed to continue lever-pressing but received
only saline injections for doing so. Over the course of this
extinction phase, response rates dropped from about 60 responses
per hour on the first trial to about 5 presses per hour at the end.
(Five presses per hour is about the baseline level of exploratory
lever-pressing we see under our testing conditions, the number of
lever-presses a naı ¨ve and non-rewarded animal makes when first
introduced to the test chamber.) In the subsequent reinstatement
test, the animals were again tested under extinction conditions but
here they were given a 10 mg/kg IP ‘‘priming’’ injection of
cocaine HCl just prior to testing. Consistent with earlier studies
[34,35] the IP priming injection caused vigorous resumption of
lever-pressing—over 50 responses in 2 h—despite the fact that no
further cocaine was earned (Fig. 1 A). The animals responded
preferentially on the one of two available response levers that had
been associated with injections of cocaine HCl in the training
phase (the previously ‘‘active lever’’), confirming that the response
reflected prior conditioning and not a simple increase in general
arousal. Minimal lever-pressing was seen in animals given IP
priming injections of vehicle (saline). As expected, similar IP
injections of cocaine HCl failed to cause significant lever-pressing
in cocaine-naı ¨ve (saline-trained) animals.
Microdialysis samples were collected from the ventral tegmental
area during the challenge session and were assayed for glutamate
and dopamine. Glutamate and dopamine levels were each elevated
by the cocaine HCl challenge injection in the cocaine-trained rats;
dopamine but not glutamate was elevated in the cocaine-naı ¨ve
(saline-trained) rats (Fig. 1B,C). This is consistent with our earlier
finding that unearned IV cocaine HCl causes ventral tegmental
glutamate release in cocaine-trained animals but not in saline-
trained animals [27], and with the earlier finding that IP cocaine
HCl causes ventral tegmental glutamate release in cocaine-
experienced animals but not in cocaine-naı ¨ve animals [31].
Unsignaled IV cocaine HCl also fails to elevate ventral tegmental
glutamate in animals that have had prior experience with unearned
cocaine HCl injections—injections that were unpredictable because
they were controlled by a ‘‘yoked’’ partner [27]. Thus, with the
exception of the present experiment, in all cases where cocaine HCl
has been found to cause release of ventral tegmental glutamate, the
animals not only had prior experience with cocaine HCl; they had
prior experience with cocaine HCl injections that were predictable,
either from their own intentional acts or from the repeated ritual of
a repeated injection regimen. A possible explanation for the present
case—where there was a glutamate response to IP cocaine HCl
injections that the animal had not experienced previously—is that
the peripheral stimulus properties of cocaine HCl, like the external
light and sound stimuli in the self-administration experiment [27]
and the IP injection ritual in the sensitization experiment [31],
served as a predictive cue, a cue that had been previously
experienced with IV cocaine HCl injections during the animal’s
self-administration history. While this possibility may seem unlikely
to those not familiar with other studies where the peripheral effects
of a drug serve asa conditioned stimulusfor their own central effects
[32,36,37], it was a possibility that we easily tested.
To test the hypothesis that IP cocaine in our first experiment
caused glutamate release because its peripheral effects had become
conditioned stimuli predictive of cocaine HCl’s central effects, we
repeated our experiment using IV cocaine HCl as the training
drug but using IP cocaine methiodide (MI)—an analogue that has
the peripheral effects of cocaine HCl but does not cross the blood
brain barrier—as the challenge drug. Like the earlier challenge
with IP cocaine HCl, challenge with equimolar IP cocaine MI
reinstated drug-seeking and caused ventral tegmental glutamate
and dopamine release (Fig. 1D,E,F). Ventral tegmental perfusion
with the glutamate antagonist kynurenic acid again attenuated
cocaine MI-induced reinstatement of lever-pressing and ventral
tegmental dopamine release, confirming that the cocaine MI-
activated glutamatergic release was responsible for activation of
the dopamine system and for the reinstatement of cocaine-seeking.
While cocaine MI was as effective as cocaine HCl in causing the
glutamate release responsible for the initial phase of the dopamine
increase (Fig. 1B vs 1E), it was less effective than cocaine HCl at
reinstating the cocaine-seeking lever-press habit (Fig. 1A vs 1D) and
at causing dendritic dopamine release (Fig. 1C vs 1F). This should
not be surprising because cocaine MI provides only the initial
glutamate input to the dopamine system, not the sustained blockade
of dopamine reuptake that accounts for the bulk of the dopamine
elevation seen after self-administered doses of cocaine HCl [6,7].
We next compared the effects of yoked IV injections of cocaine
HCl or cocaine MI on ventral tegmental glutamate and dopamine
release in cocaine HCl-trained or saline-trained rats. Here, the
injections were paced by the responding of an ‘‘executive’’ animal
that earned injections for both itself and its yoked partner. The
dosage was 1.0 mg/kg/injection for animals receiving cocaine
HCl and 1.3 mg/kg/injection (the molar equivalent of 1.0 mg/kg
of cocaine HCl) for animals receiving cocaine MI. The intervals
between injections—controlled by the executive partner—were
usually 5–6 minutes.
Glutamate was elevated equally by the initial yoked injections of
cocaine HCl (Fig. 1A) and cocaine MI in cocaine HCl-trained but
not in saline-trained animals (Fig. 1B). The elevations were
transient; glutamate returned to baseline in the first hour, while
cocaine injections continued for another three hours. Dopamine
was elevated by both yoked cocaine HCl and yoked cocaine MI,
but the elevations were dramatically different (Fig. 2C,D). In
cocaine HCl-trained animals, yoked cocaine MI caused a small
transient dopamine elevation—an elevation with a similar time-
course to that of glutamate. Yoked cocaine HCl, in contrast,
elevated dopamine levels in both cocaine HCl-trained animals
(Fig. 2B) and in saline-trained animals (Fig. 2D); moreover, it did
so for the full 4-hour session (Fig. 2B,D). The elevation was greater
in the cocaine HCl-trained animals, consistent with what is seen in
cocaine sensitization experiments [38,39,40]. The elevation was
also more immediate, with an initial peaklet in the cocaine HCl-
trained animals; if the response to cocaine MI (Fig. 2D) is
subtracted from the response to cocaine HCl (Fig. 2B), the initial
peaklet is lost and the dopamine elevations for the cocaine HCl-
trained animals simply look a bit larger than those of the saline-
trained animals (Fig. 2B, dotted line).
These data are consistent with the view that cocaine HCl has
peripheral as well as central actions that contribute the early
component to the elevation of extracellular dopamine levels. To
confirm that cocaine MI acted peripherally and did not enter the
Cocaine Conditioned Stimulus
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(Fig. 3A) and cocaine HCl (Fig. 3B) after IV injections of each.
Cocaine HCl was detected in both blood and brain (Fig. 4), with
brain concentrations about 25% lower than blood concentration
(Fig. 3B; cocaine MI was detected at similar concentration in
blood but was not detected in brain (Fig. 3A, 4). These findings
offer a simple explanation for the glutamate release seen in cocaine
HCl-trained animals that are given so-called ‘‘unsignaled’’ yoked
injections of cocaine HCl [27]. While the injections are not
signaled by cocaine-predictive exteroceptive cues, the present
findings reveal that the yoked injections are signaled by
interoceptive cocaine cues, cues associated with the peripheral
actions of cocaine.
Our main findings do not, however, explain immediate effects
of cocaine HCl that can be detected by fast-scan cyclic
voltammetry in cocaine-naı ¨ve anesthetized animals [25]. While it
is not necessarily the case that conditioned stimulus effectiveness is
blocked by anesthesia, the fact that these immediate effects of IV
cocaine HCl can be seen in cocaine-naı ¨ve animals means that
these are unconditioned responses to cocaine HCl. The immediate
and unconditioned dopamine response to cocaine HCl in
anesthetized cocaine-naı ¨ve animals does, however, offer an
interesting hypothesis for the development of the conditioned
glutamate responses reported here and in our earlier [27] study.
First, we must assume that the immediate and unconditioned
dopamine response is small and does not reflect the central
Figure 1. Mean lever-pressing (top panels) and ventral tegmental glutamate (middle panels) and dopamine (lower panels)
fluctuations during reinstatement of lever-pressing by cocaine HCl (left panels) and cocaine MI (right panels). IP injections of cocaine
HCl (10 mg/kg) or cocaine MI (13 mg/kg) were given at Time=0. Abbreviations: aCSC (artificial cerebrospinal fluid), Kyn (kynurenic acid, glutamate
antagonist), cocaine HCl (cocaine hydrochloride), cocaine MI (cocaine methiodide). The notation ‘‘Cocaine HCl-aCSF’’ indicates the condition where
the IP injection was cocaine HCl and where the dialysate included aCSF.
doi:10.1371/journal.pone.0002846.g001
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dopamine transients seen in awake, freely moving cocaine-naı ¨ve
animals given IV cocaine HCl [20]. While Mateo et al. interpret
their immediate changes in voltammetric signal to reflect a change
in dopamine uptake, this is inconsistent with the finding that the
central pharmacological effects of cocaine HCl are not evident in
awake cocaine-naı ¨ve animals for the first 10 seconds after IV
injection [20]. We question the assumption that the voltammetric
signal reflects a change in dopamine uptake. The finding of Mateo
et al. is that IV cocaine HCl increases the dopamine peak elicited
by ventral tegmental electrical stimulation, and their impression is
that the elevated peak is accompanied by a decrease in the slope of
the decay function; this interpretation is based on visual inspection
of the decay functions and on a significant increase in apparent
Km for those functions [25]. However, the Km estimate is based on
the lower portion of the peaks, where the dopamine ‘‘signature’’ of
oxidation and reduction currents tends to be lost below the
sensitivity threshold for differentiating dopamine from electrical
noise [22] and, thus, where the voltammetric signal may no longer
reflect dopamine itself. When only the upper portions of the peaks
are superimposed, the portions confirmed as dopamine signal,
there is no apparent difference in the rate of dopamine clearance
(see [25] Fig. 1).
If the effect reported by Mateo et al. reflects a minor and
immediate increase in dopamine release—rather than a minor
immediate change in dopamine reuptake—its likely cause could well
be a small unconditioned glutamate input to the dopamine system.
This brief synaptic input would not be very evident in 20-minute
microdialysis samples, but could perhaps correspond to the peaklet
seen in Fig. 2A. While this peaklet is statistically insignificant,
similar peaklets have appeared in our previous study ([27]: Fig 3B,
Cocaine Naı ¨ve group and Yoked History group). This small
unconditioned glutamate input in cocaine-naive animals might
build through Pavlovian conditioning until it becomes the large,
obvious, statistically reliable conditioned glutamate input seen in
the dialysates of cocaine-trained animals. This is the perhaps the
simplest hypothesis of how the conditioned glutamate release
arises, an hypothesis that can perhaps be tested with new
amperometric methods for rapid glutamate measurements in vivo,
methods that have a time scale of seconds [41,42] rather than the
scale of minutes typical of microdialysis studies.
While the present findings were unanticipated and have
important implications for addiction theory, they are not
inconsistent with current knowledge. It is known that reward-
predicting stimuli can activate the dopamine system, and, indeed,
can come to substitute for the reward itself in activating the
dopamine system [26]. It is also known that environmental stimuli
can come to have conditioned behavioral and physiological effects
because of their Pavlovian association with addictive drugs,
although previous reports have stressed drug-opposite rather than
drug-like conditioned effects [43,44,45,46]. It is further known that
interoceptive cues—including those associated with drugs
Figure 2. Mean glutamate top panels) and dopamine (bottom panels) fluctuations during yoked injections of cocaine HCl (left
panels) or cocaine MI (right panels) in cocaine-naı ¨ve animals or animals experienced with cocaine HCl. The dotted line in B represents
the effects in cocaine-experienced animals of the peripheral-plus-central actions of cocaine HCl (circles in B) minus the peripheral-only action of
cocaine MI (circles in D). The difference between this line and the line reflecting the effects of cocaine HCl in cocaine-naı ¨ve animals (triangles in B) is
the consequence of sensitization to cocaine in the cocaine-trained animals [40].
doi:10.1371/journal.pone.0002846.g002
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that the immediate peripheral effects of a drug can, through
Pavlovian association with the later, stronger, central effects of that
same drug, play important roles in addiction [32,36,37]. Thus the
present data simply establish peripheral cocaine discriminative
stimulus properties as a subset of the cues that can become
associated with the central effects of cocaine and can become
conditioned stimuli for cocaine-like effects on extracellular
dopamine levels that are mediated by dopamine release rather
than by blockade of dopamine uptake.
Materials and Methods
Subjects
Fifty-nine male Long-Evans rats (Charles-River, Raleigh, N.C.),
weighing 350–400 g at the time of the surgery were used. They
were housed individually under a reverse light-dark cycle (light on
at 9:30 PM) with free access to food and water. They were allowed
to acclimate to the new environment for at least for 7 days prior to
surgery. The experimental procedures followed the Principles of
Laboratory Animal Care’’ published by National Institutes of
Health (NIH publication 86-23, 1996) and were approved by the
Animal Care and Use Committee of the NIDA Intramural
Research Program.
Intracranial cannulation. Each rat was anaesthetized with
pentobarbital (30 mg/kg i.p.) supplemented with chloral hydrate
(140 mg/kg, i.p.), and mounted in a stereotaxic frame with the
incisor bar 5 mm above the intra-aural line. The skull was then
exposed and guide cannulae (CMA/Microdialysis, N. Chelmsford,
MA) were implanted above the VTA. Bilateral cannulae were
implanted in animals used for the reinstatement studies; unilateral
cannulae over the left VTA were implanted in animals used to
assay cocaine HCl and cocaine MI in brain. Stereotaxic
coordinates for the burr holes were: 5.6 mm posterior to bregma
and 2.2 mm lateral to the midline. The guide cannulae were
lowered at a 12u angle toward the midline to a depth of 6.8 mm
from the skull surface, and cemented with dental acrylic to four
stainless steel skull screws.
Intravenous catheterization. In the same surgery, a small
incision was next made to the right of the midline of the neck and
the external jugular vein was externalized and an intravenous
silastic catheter (Dow Corning, Midland, MI) was inserted with its
tip reaching right atrium. The catheter was secured to the vein
with silk suture and the other end was fed subcutaneously around
the back of the neck to exit near the back of the skull. The end was
slipped over a bent 22-gauge stainless steel cannula (Plastic One
Inc., Roanoke, VA) with a threaded head used to secure a dummy
cannula and, during testing, a dialysis probe and infusion line. The
catheter and the guide cannula were secured to the head pedestal
with dental cement and the wound was sutured.
After surgery, each rat was given 0.25 ml of sc 2.27%
enrolfloxacine once daily for three days as precaution against
infection. The animals were allowed to recover for at least 5 days
before the microdialysis or behavioral training started; during this
time the catheters were flushed daily with 0.2 mg gentamicin in
sterile saline and 0.05 ml heparin (30 U/ml in sterile saline).
Ten of the rats were used in the measurement of cocaine HCl
(n=5) and cocaine MI (n=5) levels in brain and blood. This was
done at the time of surgery, while the animal remained
anesthetized. For these animals, guide cannulae were not used; a
microdialysis probe (CMA/12 14/02, CMA/Microdialysis) was
simply implanted directly into the left VTA to a depth of 8.8 mm
from the skull, the same penetration as was used in the behavioral
studies. In these animals, a second microdialysis probe (CMA 20
Elite 14/10 PAES, CMA/Microdialysis) was inserted directly into
the right jugular vein.
Cocaine self-administration training
After recovery from surgery, 49 animals were given the
opportunity to self-administer IV cocaine in daily (6 days/week)
four-hour ‘‘training’’ sessions. No priming or shaping was used.
Each rat’s catheter was first connected by polyethylene tubing to a
microprocessor-controlled syringe pump (Razel Scientific instru-
ments, Stamford, CT), through a feed-through swivel that allowed
freedom of movement, and the rat was then placed in a dimly (red)
lit operant chamber. The chamber was equipped with two operant
levers, one fixed and one retractable (Med Associates, Georgia,
VT), 9 mm above the floor. Training sessions began with the
insertion of the retractable lever into the chamber and illumination
of a 15w house light that remained on throughout the session.
Each depression of the retractable lever (designated the ‘‘active’’
lever) caused delivery of intravenous cocaine (1 mg/kg/injection;
6 groups of n=6–7) or saline (two cocaine-naı ¨ve ‘‘control’’ groups;
n=6 each), in a volume of 0.13 ml, delivered over 4.5 seconds. A
Figure 3. Levels of free and methylated cocaine (M Cocaine) in
blood and brain following IP injections of cocaine MI (13 mg/
kg) (top panel) or cocaine HCl (10 mg/kg) (bottom panel).
Cocaine HCl dissociates at physiological pH and free cocaine enters the
brain readily. The methyl group does not dissociate readily from
cocaine MI at physiological pH, and the methylated quaternary salt
does not cross the blood brain barrier.
doi:10.1371/journal.pone.0002846.g003
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the infusion and remained illuminated for 20 s during a ‘‘time
out’’ in which further lever pressing was ineffective. Depressions of
the fixed lever (designated the ‘‘inactive’’ lever) were recorded but
had no consequences for the animal. No priming injections or
response shaping were given. The training sessions lasted two
weeks.
Extinction training
After the completion of self-administration training, rats to be
used in the reinstatement study (two groups, n=6 and n=7)
underwent extinction sessions. Here each lever-press delivered
only saline (0.13 ml/injection) and sessions continued for each
animal until its response rate dropped to fewer than 15 responses
per 4-h session; this was the baseline level of responding seen in
control animals introduced to the chambers with no reinforce-
ment. This criterion was reached after 14–18 sessions with saline
substitution.
Reinstatement testing
Four groups of animals (n=6–7) were tested for reinstatement
of their lever-pressing habit one to four days after extinction trials
were completed. Each animal was tested in four conditions, two
per day over two days. Two groups were tested with cocaine HCl
(10 mg/kg, IP); two were tested with cocaine MI (13 mg/kg, IP).
On the first day, half the animals were tested for reinstatement of
lever-pressing after an IP challenge injection of their assigned
cocaine salt and half were challenged after an IP injection of
saline. On the second day the challenges were reversed. For the
morning test each day, aCSF was in the dialysate; for the
afternoon aCSF plus 1 mM Kyn was in the dialysate. The timeline
for this testing is given below.
Yoked injections
The effects of prior experience self-administering cocaine HCl
on the neurochemical effects of cocaine HCl or cocaine MI on
ventral tegmental glutamate and dopamine fluctuations were
assessed in rats given subsequent unpredictable IV injections of
each challenge drug. Two groups (cocaine HCl-experienced; n=6
each) were trained to self-administer IV cocaine HCl as described
above; two groups (cocaine-naı ¨ve; n=6 each) were given the same
handling and training routine but with saline as the solution that
could be self-administered. One cocaine HCl-experienced group
and one cocaine-naı ¨ve group were given yoked cocaine HCl; one
Figure 4. Illustrative chromatograms from blood (red line) and brain (blue line) dialysates taken from an animal given IP cocaine MI
(13 mg/kg) (top panel) and an animal given IP cocaine HCl (10 mg/kg) (bottom panel). The green line shows a chromatogram from a
standard solution containing free cocaine, methylated cocaine, and the primary cocaine metabolite bonzoylecgonine.
doi:10.1371/journal.pone.0002846.g004
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were given yoked cocaine MI.
Yoked cocaine injections are injections that the animal receives
passively, under the control of another animal: an ‘‘executive’’
partner to which the experimental animal is said to be ‘‘yoked.’’
The two animals are yoked together in the sense that whenever
one animal receives an injection the other animal receives the
same injection or a comparison injection at the same time. In the
present case, IV injections of cocaine HCl (1 mg/kg/injection:
n=6) or cocaine MI (1.3 mg/kg/injection: n=6) were passively
received by animals yoked to the earned injections of IV cocaine
HCl (1 mg/kg/injection) by an executive animal. Here the 4-h
sessions were initiated by insertion of the response lever into the
cage of the executive animal; response levers were not inserted into
the cages of any of the yoked animals, and cue light illumination
did not accompany the injections for the yoked animals. Thus the
only cues that predicted the yoked injections were the interocep-
tive cues associated with the injections themselves.
In vivo microdialysis testing
Reinstatement tests. The rats in the reinstatement
experiments were connected to the microdialysis systems and
placed in the test chambers (with the response lever retracted) the
evening before the microdialysis tests. Each rat’s blocker was
removed from the guide cannulae, the microdialysis probe was
inserted and fixed in position, and the probes were connected to
the microdialysis pump (CMA/100) with FEP tubing through a
three-channel fluid swivel. The probes were perfused over night
with an artificial cerebrospinal fluid (aCSF, composition in mM:
NaCl, 148; KCl, 2.7; CaCl2, 1.2; MgCl2, 0.8, pH 7.4) at a flow
rate of 0.4 ml/min. The following morning the flow rate was
increased to 1.2 ml/min. After 20 minutes for equilibration, a
series of five 20-min baseline samples were collected. Then the
animals were removed from the chamber, given the assigned
challenge injection for that day (one of the cocaine challenges or
the saline control challenge), and replaced in the test chamber.
The response lever was inserted into the chamber and the animals
were allowed to lever-press during two-hour reinstatement tests in
which responding was not reinforced. At the end of this test the
perfusion solutions were changed to aCSF containing 1 mM of
kynurenic acid and the procedure (20 min equilibration, 5 baseline
samples, IP injection, testing) was repeated (with the same
challenge) for the second session of the day. Comparison groups
of untrained (cocaine-naı ¨ve) rats were not challenged with Kyn
and were tested in a single condition (perfusion with aCSF and
challenge with IP cocaine HCl or cocaine MI). The timeline for
the trained animals was as follows:
0900h: Kyn in perfusate given to assigned groups
0920h: Baseline sampling begins
1100h: IP cocaine or saline; lever insertion; reinstate-
ment test begins
1300h: End of test, lever retracted.
1500h: Kyn in perfusate given to assigned group
1520h: Baseline sampling again
1700h: IP cocaine or saline; lever insertion; second test
begins
1900h: End of test, lever retracted.
Yoked injections. Following their training periods, four
groups (n=6 each) underwent microdialysis testing in which
they received a series of unearned injections of IV cocaine HCl or
cocaine MI injections yoked to the behavior of a rat self-
administering an equimolar dose (1.0 mg/kg) of cocaine HCl.
Again, the rats were put in the self-administration chambers and
connected to the microdialysis systems the night before testing and
perfused at 0.4 ml/min overnight. The next morning the infusion
rate was increased to 1.0 ml/min and five baseline samples were
taken. Then the yoked cocaine MI injections were started. In these
tests the response lever was never inserted and the cue light was
never illuminated. Samples were collected for four hours.
Brain cocaine and cocaine methiodide concentration
determinations. Cocaine HCl and MI concentration were
determined in blood and brain following IP injection in
anesthetized animals. Here three baseline microdialysis samples
were collected immediately following insertion of probes into the
jugular vein and the VTA. Then the animals were given IP
injections of cocaine HCl (10 mg/kg) or cocaine MI (13 mg/kg)
and 20-min microdialysis samples were collected for another
80 min. A supplementary dose of anesthetic was given when a rat
began to show signs of responsiveness to paw pressure.
Biochemical analysis of microdialysis samples
Glutamate. Glutamate was measured using a high
performance liquid chromatography (HPLC) system using a
model 582 HPLC pump (ESA, Inc., Chelmsford, MA), a CMA/
260 degasser, a CMA/200 refrigerated microsampler, a phase II
ODS column (3 mm particle size, 3.26100 mm, Bioanalytical
Systems, Inc., West Lafayette IN), a CMA/280 fluorescence
detector and an ESA model 501 data station (ESA, Inc.). The
CMA/280 is a fixed wavelength fluorescence detector operating at
a maximal excitation of 330–365 nm and emission of 440–
530 nm. The precolumn derivatization of glutamate was
performed with an o-phthalaldehyde/mercaptoethanol reagent
(0.4 M borate, 0.04 M phthalaldehyde and 0.4 M 2-
mercaptoethanol, pH 10.4). Ten ml of the reagent was added to
and mixed with the samples by the microsampler. After a 60 s
reaction period at 6u
loC in the microsampler, 20 ml of the mixture
was injected onto the column. The elution of glutamate was
achieved with a mobile phase consisting of 0.15 M sodium acetate,
10% methanol and 1.5% tetrahydrofuran at a flow rate of 0.6 ml/
min. Following the appearance of the glutamate peak on the
chromatogram, an injection of 20 ml of 100% methanol was made
by the microsampler before the end of the chromatogram in order
to accelerate the elution of the residuals on the column. The
detection limit was 0.2 pmol/injection.
Dopamine. Dopamine was measured using a HPLC system
using an ESA Coulochem II Detector (model 5200) with a dual-
electrode microdialysis cell, and an ESA model 501 data station
(ESA, Inc.). Samples were manually injected onto the column
(3 mm particle size, 3 mm6150 mm, Analytical MD-150, ESA,
Inc.). The mobile phase for DA separation consisted of 75 mM
NaH2PO4, 1.5 mM OSA, 10 mM EDTA, and 8% acetonitrile
(pH 3.0 adjusted with H3PO4) delivered at a flow rate of 0.5 ml/
min. Dopamine was quantified on both reducing (2250 mV) and
oxidizing electrodes (350 mV). The limit of detection for
dopamine was approximately 5-fmole/injection.
Cocaine HCl and cocaine MI. Cocaine HCl dissociates in
saline solution at physiological pH, and free cocaine elutes early
under our HPLC conditions. The methyl group in cocaine MI
does not dissociate from free cocaine in saline solution at
physiological pH, and methylated cocaine elutes much later than
free cocaine under our conditions. Thus we looked for cocaine and
methylated cocaine peaks in brain and blood samples of animals
given IP injections of cocaine HCl (10 mg/kg) or cocaine MI
(13 mg/kg) samples. The mobile phase consisted of 0.25 M
sodium acetate, 0.1 mM tetrabutylammonium phosphate, 15%
Cocaine Conditioned Stimulus
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pH 6.5 for optimal separation of the two drugs and delivered onto
the column (5 mm particle size, 2 mm6250 mm, Capcell-C18,
ESA, Inc.) at a flow rate of 0.4 ml/min. Cocaine and methylated
cocaine were detected using a Waters 2475 Multi l Fluorescence
Detector (Waters Corp., Milford, MA) with excitation and
emission wavelengths set at 225 and 315 respectively and
quantified by the ESA data system. The detection limits for
cocaine and methylated cocaine were approximately 0.1 ng/
injection.
Drugs
Cocaine HCl, cocaine MI, and the anesthetic used in the
surgery were obtained from the pharmacy department within the
institute. Kyn and chemicals used for HPLC were purchased from
Sigma-Aldrich Corporation (St. Louis, MO). Kyn was first
dissolved with a small aliquot of 5N NaOH and diluted with
aCSF to the final concentrations. The drug solution was adjusted
to pH 7.4 before use. Cocaine HCl and cocaine MI were dissolved
in physiological saline at equal molar concentration for both IP
injection and intravenous infusion.
Histology
After the completion of the microdialysis experiments, the rats
were decapitated under anesthesia and the brains were removed
and post-fixed for 7 days in 10% formalin solution. The brains
were then frozen and 50 mm coronal sections were taken. Probe
placement was determined under low magnification in wet
sections that differentiate fiber bundles from cell body regions
and thus identify classic brain landmarks.
Statistical analysis
The substance levels are expressed as the concentrations found
in the perfusate (means6S.E.M.). Basal values refer to those
obtained before the drug was infused or before the start of
behavioral testing. When data are expressed as percent of baseline
values, the mean concentration of the three samples preceding the
drug infusion or the behavioral test is defined as 100%. The drug
effects between treatment groups were analyzed with two-way
analysis of variance (ANOVA) with repeated measures over time
followed by Fisher’s PLSD test. The drug effect within a treatment
group was analyzed with one-way ANOVA with repeated
measures over time followed by Dunnet’s test. The effects of the
drugs on lever-press rate were analyzed using two-way ANOVA
with repeated measure over time followed by Fisher’s PLSD test.
The level of P,0.05 was the criterion for statistical significance
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